Disparities in the Treatment of Patients with Interstitial Lung Disease in Canada

被引:0
|
作者
Assayag, D. [1 ]
Garlick, K. [2 ]
Johannson, K. A. [3 ]
Fell, C. D. [4 ]
Kolb, M. R. J. [5 ]
Cox, G. P. [6 ]
Hambly, N. [7 ]
Manganas, H. [8 ]
Morisset, J. [9 ]
Fisher, J. H. [10 ]
Shapera, S. [11 ]
Sadatsafavi, M. [12 ]
Wilcox, P. [13 ]
Halayko, A. J. [14 ]
Khalil, N. [13 ]
Ryerson, C. J. [15 ]
机构
[1] McGill Univ, Pulm, Montreal, PQ, Canada
[2] Boehringer Ingelheim GmbH & Co KG, Pulm, Toronto, ON, Canada
[3] Univ Calgary, Med, Calgary, AB, Canada
[4] Univ Calgary, South Hlth Campus, Calgary, AB, Canada
[5] McMaster Univ, Hamilton, ON, Canada
[6] St Josephs Hlth Care, Hamilton, ON, Canada
[7] McMaster Univ, Respirol, Hamilton, ON, Canada
[8] CHUM, Med, Montreal, PQ, Canada
[9] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[10] Univ Toronto, Toronto, ON, Canada
[11] Univ Toronto, Med, Toronto, ON, Canada
[12] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[13] Univ British Columbia, Vancouver, BC, Canada
[14] Univ Manitoba, Physiol Internal Med Respirol, Winnipeg, MB, Canada
[15] Univ British Columbia, Dept Med, Vancouver, BC, Canada
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5624
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Treatment Initiation in Patients with Interstitial Lung Disease in Canada
    Assayag, Deborah
    Garlick, Kristopher
    Johannson, Kerri A.
    Fell, Charlene D.
    Kolb, Martin
    Cox, Gerard
    Hambly, Nathan
    Manganas, Helene
    Morisset, Julie
    Fisher, Jolene H.
    Shapera, Shane
    Gershon, Andrea S.
    To, Teresa
    Sadatsafavi, Mohsen
    Wilcox, Pearce G.
    Halayko, Andrew J.
    Khalil, Nasreen
    Ryerson, Christopher J.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (10) : 1661 - 1668
  • [2] Disparities in Oxygen Initiation for Interstitial Lung Disease in Canada
    Marino, A.
    Assayag, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [3] Interstitial lung disease in patients with scleroderma - Treatment with rituximab
    A Muñoz
    R Martínez
    S Rodríguez
    M L Velloso
    J L Marenco
    Journal of Translational Medicine, 8 (Suppl 1)
  • [4] INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SCLERODERMA: TREATMENT WITH RITUXIMAB
    Munoz, A.
    Martinez, R.
    Leon, M.
    Gallo, F.
    Velloso, M. L.
    Rodriguez, S.
    Mayordomo, L.
    Rejon, E.
    Marenco, J. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 : A78 - A78
  • [5] Treatment and Prognosis of Patients with Lung Cancer and Combined Interstitial Lung Disease
    Mauclet, Charlotte
    Dupont, Michael V.
    Roelandt, Kerwin
    Regnier, Maxime
    Delos, Monique
    Pirard, Lionel
    Vander Borght, Thierry
    Dahlqvist, Caroline
    Froidure, Antoine
    Rondelet, Benoit
    Vanderick, Jean
    Remouchamps, Vincent
    Duplaquet, Fabrice
    Ocak, Sebahat
    CANCERS, 2023, 15 (15)
  • [6] Global challenges and disparities of care for interstitial lung disease
    Singh, Sheetu
    Chaudhuri, Nazia
    Samarasekera, Bodhika
    RESPIROLOGY, 2024, 29 (07) : 548 - 550
  • [7] Racial Disparities In Survival Of Interstitial Lung Disease (ild) Patients Independent Of Ild Phenotype
    Hawley, J. E.
    Kawut, S. M.
    Peterson, E. R.
    Philip, N.
    Arcasoy, S. M.
    Lederer, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [8] TREATMENT OF A COHORT OF PATIENTS WITH INTERSTITIAL LUNG DISEASE AND RHEUMATOID ARTHRITIS
    Aguilera Cros, C.
    Gomez Vargas, M.
    Gil Velez, R. J.
    Rodriguez Portal, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 978 - 978
  • [9] Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
    Mohammed, Abdel Gaffar A.
    Alshihre, Ammar
    Al-Homood, Ibrahim Abdulrazag
    ANNALS OF THORACIC MEDICINE, 2017, 12 (04) : 294 - 297
  • [10] Current and emerging treatment options for interstitial lung disease in patients with rheumatic disease
    Lee, Joyce S.
    Fischer, Aryeh
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (05) : 509 - 520